MannKind | MNKD - Market Capitalization


MannKind reported $1.02B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Insmed USD 19.68B 3.43B Aug/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
MannKind USD 1.11B 207M Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Novavax USD 1.09B 316M Dec/2025
Novo Nordisk DKK 159.32B 52.85B Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Xencor USD 1.21B 19M Aug/2026